Taking Wegovy Every 5 Days: What the Evidence Actually Says

The misconception: more frequent injections mean faster results

It's a logical leap. If one injection per week produces weight loss, surely injecting every five days would accelerate things? In practice, this reasoning misunderstands how semaglutide works in the body.

Semaglutide has a plasma half-life of roughly seven days. That means the medicine is still active, still binding to GLP-1 receptors, still slowing gastric emptying and signalling fullness, well after your injection day. The once-weekly schedule isn't a rough approximation, it's calibrated to maintain a stable, therapeutic level in your bloodstream without accumulation. Compressing the interval pushes that level higher without any licensed evidence that the extra exposure translates into greater weight loss. What it does do is increase the likelihood of nausea, vomiting, or other gastrointestinal side effects that the titration schedule was designed to minimise. The NHS patient information for semaglutide is unambiguous: one injection per week, on the same day each week if possible.

If you've been taking your injections slightly early because of scheduling clashes, the general guidance is that a day or two of flexibility in either direction is a practical reality, but that's a conversation for your prescriber or pharmacist, not a self-modified routine. If you're wondering whether a slightly longer stretch between doses is safe, our page on taking Wegovy every ten days explains the clinical picture for that interval specifically.

What actually happens when the dose interval shortens

The titration schedule built into Wegovy (starting at 0.25 mg and stepping up roughly every four weeks through to 2.4 mg) exists specifically to give your digestive system time to adjust. Most people who experience nausea find it peaks in the first few days after an injection or a dose increase, then settles. Shortening the interval means the next dose arrives before that window has fully closed.

In practice, this tends to produce one of two outcomes: either the side effects compound (persistent nausea, reduced appetite beyond what's helpful, dehydration), or people feel so unwell they delay the injection anyway, which ironically lengthens the interval rather than shortening it. Neither is the controlled, clinical approach that gets results. The NICE technology appraisal for semaglutide (TA875) is built around the licensed dosing schedule, the evidence base for Wegovy's effectiveness comes from trials that used it exactly as prescribed.

Some readers land on this page because they've missed a dose and are trying to decide how to catch up. That's a slightly different situation, and the Patient Information Leaflet covers it specifically. If a dose was more than five days late, the standard advice is to skip that dose and take the next one on the usual scheduled day. A missed dose handled calmly is safer than a rushed catch-up.

When to speak to a prescriber instead of adjusting the schedule yourself

If you're researching every-five-days dosing because your weight loss has plateaued, that's a sign the conversation you need is with a prescriber, not a tweak to the calendar. A plateau is normal (the body adapts) and the licensed response is to review whether a dose increase is clinically appropriate, not to crowd injections closer together.

Wegovy's dose pathway runs from 0.25 mg through to a maintenance dose of 2.4 mg weekly, and from January 2026 a 7.2 mg higher maintenance option became available following MHRA approval, extending options for people who respond partially to the standard maintenance dose. None of those options involve changing the frequency of injections. Our overview of Wegovy as a treatment covers the dose pathway and what to expect from each stage.

For anyone thinking about starting or reviewing semaglutide treatment, it's also worth reading about the BMI criteria that apply to Wegovy, since eligibility is one factor a prescriber weighs alongside current progress. If you're curious about how slightly different intervals get discussed by people on treatment, the question of taking Wegovy every six days is answered separately, and the broader picture of extending to a two-week gap raises different but equally important clinical considerations.

What to do if you have concerns about your current treatment

The right route for any concern about timing, dose, or progress is a clinical one. Self-adjusting a prescription medicine's schedule carries real risks, and (because Wegovy is a prescription-only medicine) any change in how it's used should be agreed with the prescriber who issued the prescription.

If you're currently receiving treatment elsewhere and feel under-supported, or if you haven't started yet and want to understand your options properly, our prescribers review consultations the same day. There's no waiting list for an initial review, and aftercare is available seven days a week. You can read more about how to access Wegovy from a regulated UK pharmacy, or explore the full range of weight-loss treatment options to see what might suit your situation. For a broader view of what our pharmacy offers and how it operates, the about us page sets out our clinical model clearly.

If you do have questions that aren't covered here, our team is reachable through the contact page. And when you're ready to speak to a prescriber, start your free consultation, a real clinician reads your answers the same day.